Jennifer Faigle serves as Counsel at Lung Therapeutics, where she plays a pivotal role in shaping the legal framework that supports the organization’s strategic objectives. With a strong background in legal matters, Jennifer is dedicated to creating, developing, and implementing a robust legal function that...
Jennifer Faigle serves as Counsel at Lung Therapeutics, where she plays a pivotal role in shaping the legal framework that supports the organization’s strategic objectives. With a strong background in legal matters, Jennifer is dedicated to creating, developing, and implementing a robust legal function that effectively advises business teams across various departments, including manufacturing, clinical, pre-clinical, and finance. Her expertise in commercial transactions and legal writing allows her to navigate complex agreements with ease, ensuring that the organization mitigates business risks while maintaining compliance with industry regulations.
One of Jennifer's key projects involves improving and streamlining the agreement review process. By updating and creating contract templates, she enhances the efficiency of negotiations and expedites the decision-making process. Her analytical skills and attention to detail enable her to review risks in collaboration with business partners, ensuring that all agreements align with the company’s strategic goals. Additionally, Jennifer's proficiency in intellectual property law and trade secrets is instrumental in developing and managing the patent portfolio, safeguarding the organization’s innovations in the competitive biopharmaceutical landscape.
As an exceptional relationship builder and project manager, Jennifer fosters strong communication channels across departments, facilitating a culture of accountability and collaboration. Her goal-oriented approach, combined with her business intelligence skills, empowers Lung Therapeutics to navigate the complexities of the healthcare industry effectively. Through her leadership, the legal team not only supports the organization’s immediate needs but also positions it for long-term success in advancing therapeutic solutions for patients with lung diseases.
